Genomic instability is a key hallmark of cancer leading to tumour heterogeneity and therapeutic resistance. BRCA2 has a fundamental role in error-free DNA repair but also sustains genome integrity by promoting RAD51 nucleofilament formation at stalled replication forks. CDK2 phosphorylates BRCA2 (pS3291-BRCA2) to limit stabilizing contacts with polymerized RAD51; however, how replication stress modulates CDK2 activity and whether loss of pS3291-BRCA2 regulation results in genomic instability of tumours are not known. Here we demonstrate that the Hippo pathway kinase LATS1 interacts with CDK2 in response to genotoxic stress to constrain pS3291-BRCA2 and support RAD51 nucleofilaments, thereby maintaining genomic fidelity during replication stalling. We also show that LATS1 forms part of an ATR-mediated response to replication stress that requires the tumour suppressor RASSF1A. Importantly, perturbation of the ATR-RASSF1A-LATS1 signalling axis leads to genomic defects associated with loss of BRCA2 function and contributes to genomic instability and 'BRCA-ness' in lung cancers.
Replication stress occurs when the progression of a DNA replication fork is impeded by base lesions, insufficient nucleotides (for example, hydroxyurea, hypoxia) or oncogene-enforced errors and is typified by accumulation of single-stranded DNA (ssDNA; refs [1] [2] [3] [4] [5] . Increasing evidence suggests that failure to appropriately protect this ssDNA leads to nucleolytic attack, compromising the integrity of nascent DNA at stalled forks and resulting in increased chromosomal aberrations in human precancerous lesions [6] [7] [8] [9] . Recently 10 , components of the homologous recombination pathway have been identified to have a repair-independent function that protects nascent DNA at stalled replication forks [8] [9] [10] [11] . BRCA1/2 and FANCD2 tumour suppressors promote the formation of RAD51 nucleofilaments on ssDNA at stalled forks to prevent MRE11 nucleolytic activity and thereby facilitate restart after resolution of replication stress [8] [9] [10] [11] [12] [13] . Failure to efficiently stabilize RAD51 nucleofilaments at stalled forks leads to DNA damage and is purported to be the source of the genomic instability observed in BRCA1/2-mutation carriers and Fanconi anaemia patients 9 .
Formation of a nucleofilament requires initial association of RAD51 monomers with BRC repeats of BRCA2 before polymerization onto ssDNA. An additional contact of polymerized RAD51 with the carboxy-terminal TR2 domain of BRCA2 stabilizes the nucleoprotein filament specifically at replication forks 8, 14, 15 . CDK-dependent phosphorylation of Ser 3291 within the TR2 domain of BRCA2 decreases binding affinity for polymerized RAD51, resulting in nucleofilament disruption 16 . Following genotoxic stress, levels of pS3291-BRCA2 are reported to decrease to ensure that RAD51 filament stabilization can contribute to fork protection and homologous recombination 8, 16 . LATS1 is a central Ser/Thr kinase of the Hippo (MST) tumour suppressor pathway 17, 18 that restricts malignant transformation 19 . We previously reported that activation of MST2 in response to DNA damage requires direct phosphorylation of RASSF1A on Ser 131 by the apical sensor of DNA double-strand breaks, ATM. In response to ATM activation, MST2 targets LATS1, which in turn phosphorylates the transcriptional co-activator YAP1 promoting its interaction with p73 and induction of apoptosis 20 . Phosphorylation of Ser 131 promotes RASSF1A dimerization and orientates the associated MST2 monomers to allow stimulation of MST2 kinase activity 20 .
The minor allele of a common single nucleotide polymorphism (RASSF1 c.397G>T) results in RASSF1A-A133S, which fails to get phosphorylated by ATM or activate MST2-LATS1 (ref. 21 ) and is associated with poor overall survival and early cancer onset A R T I C L E S in BRCA2-mutation carriers [22] [23] [24] . RASSF1A is also a frequent site of epigenetic inactivation in sporadic human malignancies with increasing prognostic significance across multiple tumour types [25] [26] [27] . Thus, loss of function through genetic or epigenetic routes can lead to RASSF1A inactivation, loss of Hippo pathway signalling and promotion of malignant transformation.
LATS1 was identified in a screen for ATM/ATR-responsive substrates that are required for genomic stability 28 . In this study we show that in response to fork stalling LATS1 interacts with CDK2, restricting pS3291-BRCA2 and thereby facilitating RAD51 nucleofilament stability. This interaction relies on the ATM-and Rad3-related kinase (ATR), the main sensor of replication stress 29 that phosphorylates RASSF1A on Ser 131 to activate LATS1. We find that the RASSF1A-LATS1 signalling cascade is required during genotoxic stress to support nascent DNA stability at stalled forks. Moreover, we provide evidence that compromised signalling through genetic or epigenetic events leads to accumulation of chromosomal aberrations and introduction of a 'BRCA-ness' phenotype in tumours.
RESULTS

LATS1 is necessary for establishment of RAD51 nucelofilaments in response to stress
To gain insight into LATS1 function in response to genotoxic stress we compared the cell cycle profiles of mouse embryonic fibroblasts (MEFs) derived from mice genetically ablated for Lats1 with their wild-type littermates after exposure to gamma irradiation (γIR). In line with the findings presented in the genetic screen performed in ref. 28 , loss of LATS1 through genetic ablation (Lats1 −/− MEFs) or siRNA-mediated silencing results in enhanced G 2 /M retention of cells experiencing genotoxic stress ( Fig. 1a and Supplementary Fig. 1a ). We found that irradiated cells accumulate in G 2 /M owing to elevated levels of γH2AX, a marker of DNA damage and replication fork stalling 12 , which persisted in Lats1 −/− MEFs ( Fig. 1b and Supplementary Fig. 1b,d ) and LATS1-depleted U2OS cells ( Supplementary Fig. 1c ,e) but was resolved in control cells. To confirm that high γH2AX levels are indeed due to increased DNA damage, cells were subjected to alkaline single-cell electrophoresis where bright comet tails indicate chromatin unwinding as a result of DNA breaks. As observed for γH2AX, Lats1 −/− MEFs similarly exhibited more DNA breaks ( Supplementary Fig. 1f ) and re-expression of LATS1 or a kinase-dead derivative LATS1-D846A (LATS1-KD) rescued the phenotype, indicating that LATS1 functions to protect against DNA damage independently of kinase activity ( Fig. 1b and Supplementary  Fig. 1b,d,f) . We reasoned that LATS1 either facilitates DNA repair or prevents excessive DNA damage on genotoxic stress during S phase. The authors of ref. 28 previously observed that loss of LATS1 leads to increased γH2AX levels and suggested a potential role in homologous recombination, the main DNA double-strand break repair pathway in S phase cells. To test whether LATS1 facilitates DNA repair through homologous recombination, we first assessed recombination competence using the I-SceI assay, where homologous recombination activity is required to restore a functional copy of GFP and can be scored by fluorescence-activated cell sorting. We also monitored RAD51 foci by immunofluorescence as a marker of BRCA2-mediated loading of RAD51 onto resected DNA at break sites, which is a prerequisite for homologous recombination.
Surprisingly, whereas depletion of LATS1 did not result in significant differences in homologous recombination competence ( Fig. 1c and Supplementary Fig. 2a ), RAD51 foci were retarded in response to γIR (Supplementary Fig. 2b ). This suggests that elevated γH2AX due to LATS1 ablation is associated with ineffective RAD51 nucleofilament formation. RAD51 catalyses DNA strand exchange to provide a template for homologous recombination 30 ; however, RAD51 also functions in genome protection through a homologousrecombination-independent pathway by forming nucleofilaments that stabilize stalled replication forks 9, 10, 31 . To determine whether LATS1 contributes to RAD51 foci establishment at stalled forks we depleted nucleotide pools with hydroxyurea (HU) to specifically arrest replication forks. After 6 h of HU exposure, RAD51 foci were evident in control cells (Fig. 1d ) and importantly these were independent of homologous-recombinationassociated repair of double-strand breaks (p53BP1 +ve ) that occur at later time points (>10 h HU; refs 32,33) . In response to HU-induced stalled forks, wild-type MEFs form protective RAD51 filaments on nascent ssDNA; however, RAD51 foci fail to establish in Lats1
MEFs under the same conditions (RAD51 +ve /p53BP1 −ve cells in Fig. 1d ). Reconstitution of Lats1 −/− MEFs with either LATS1 or a LATS1 kinase-dead derivative (LATS1-KD) restored RAD51 foci, indicating that LATS1 promotes RAD51 nucleofilaments at stalled replication forks (Fig. 1d) . We found that MST2-mediated activation of LATS1 is required to establish RAD51 foci, but the classical substrate YAP is dispensable, correlating with a kinase redundant role for LATS1 and a regulatory output for the Hippo pathway independent of YAP ( Supplementary Fig. 2c ). Interestingly, despite the well-described role of LATS1 in the regulation of tissue size, discrepancies between the ablation of Lats1 in mice and conditional expression of constitutive Yap1 mutants in murine liver suggest the existence of additional mechanisms through which LATS1 suppresses tumour formation [34] [35] [36] , most notably the potential kinase-independent regulation of CDK (ref. 37) . Moreover, LATS1 has been shown to interact with CDK1 in mitosis modulating its kinase activity 37 .
LATS1 interacts with CDK2 in response to stress and modulates BRCA2 phosphorylation Exogenous expression of LATS1 homologues has shown that restriction of CDK kinase activity is conserved 37 , but the physiological relevance of an endogenous complex has remained elusive. As CDK activity is reported to destabilize RAD51 nucleofilaments, we considered that LATS1 may exert its effects through modulation of CDK activity. In agreement with previous evidence, we were unable to detect an interaction between CDK1/2 and LATS1 in cycling cells; however, on exposure of cells to γIR-or HU-induced replication fork stalling, association of endogenous CDK2 and LATS1 was readily observed in reciprocal immunoprecipitates (Fig. 2a) . To map the LATS1-CDK2 interaction we generated LATS1 deletion mutants (Fig. 2b ) that indicated that binding occurs in the amino terminus (Fig. 2b, lanes 1, 4) and requires residues 1-200 (Fig. 2b, lanes 2,  3 and 5 ), which encode a ubiquitin-associated (UBA) domain that directs distinct biological functions of LATS paralogues 38, 39 . In line with defective CDK2 association, the LATS1 200 derivative was also incapable of establishing RAD51 foci (Fig. 2c) . As previously reported for wts-cdc2 and LATS1-CDK1 complexes 37 , we find 
Untreated 4 h HU 6 h HU (d) Lats1 +/+ , Lats1 −/− , Lats1 −/−mycLATS1 and Lats1 −/−mycLATS1KD MEFs were treated with HU for 4 or 6 h, fixed and assessed for RAD51 and p53BP1 foci formation. The percentage of RAD51-positive cells without double-strand breaks (negative for p53BP1 staining) was quantified and is presented. At least 300 cells were scored per condition in n = 3 independent experiments. Error bars represent standard deviation. Statistical significance was determined by a two-tailed t-test. * P < 0.05, * * P < 0.01. Scale bars, 10 µm. Uncropped images of blots are shown in Supplementary Fig. 8 . that cyclin partners were excluded from the CDK2 fraction that co-immunoprecipitates with LATS1, leading to loss of substrate targeting and kinase activity (Fig. 2d) .
A R T I C L E S
CDK2-mediated C-terminal phosphorylation of BRCA2 leads to unstable RAD51 nucleofilaments 16 ; therefore, we reasoned that LATS1 may facilitate RAD51 foci at stalled forks by preventing phosphorylation of S3291-BRCA2. To test this we addressed pS3291-BRCA2 levels after γIR and HU exposure and found a pronounced elevation of pS3291-BRCA2 in the absence of LATS1, whereas exogenous LATS1 expression restores control levels ( Fig. 2e and Supplementary Fig. 3a ). Following γIR, pS3291-BRCA2 levels decrease to facilitate fork stability and homologous recombination 16 ; however, loss of LATS1 results in maintenance of phosphorylation levels and correlates with lower levels of RAD51 foci and increased damage (Figs 1b,d and 2e and Supplementary Fig. 2b ). In nocodazolearrested cells, where CDK1 is responsible for pS3291-BRCA2 (refs 16,40) , higher but identical kinetics to cycling cells were observed, in keeping with the ability of LATS1 to associate with CDK1 ( Supplementary Fig. 3a ). Furthermore, in vitro phosphorylation of a TR2-domain peptide indicates that CDK2 activity was lower in 
γIR-treated Lats1
+/+ compared with Lats1 −/− MEFs ( Supplementary  Fig. 3b ). Together, these data provide a model where LATS1 binds CDK2, inhibiting BRCA2-TR2 domain phosphorylation, and allows RAD51 filament assembly on ssDNA in response to genotoxic stress.
Activation of RASSF1A by ATR is necessary for LATS1 binding to CDK2
In response to DNA damage, RASSF1A activates the Hippo cascade through MST2 and LATS1 (refs 20,41) . In H1299 lung cancer cells that lack RASSF1A owing to promoter methylation 27 , LATS1 is unable to associate with CDK2 in response to either HU or γIR (Fig. 3a, lanes  4 and 7) , but the interaction was restored on RASSF1A expression (Fig. 3a, lanes 5 and 8) . In response to DNA double-strand breaks, ATM targets RASSF1A on Ser 131, but fails to activate the genetic variant RASSF1A-A133S at the same recognition site 21 . In contrast to wild-type RASSF1A, expression of RASSF1A-A133S could not rescue association with CDK2 (Fig. 3a, lanes 6 and 9) . We next addressed the levels of pS3291-BRCA2 in response to stress after RASSF1A depletion Lats1 -/-(6.6 ± 0.14 μm) Lats1 -/-mycLATS1 (10.3 ± 0.6 μm) and Rassf1A −/− FLAG-R1A-A133 MEFs exposed to 2 mM HU. Representative pictures for each condition are shown in Supplementary Fig. 4d . Western blots indicate FLAG-RASSF1A expression (the asterisk indicates a nonspecific band in MEF lysates). The sketch above delineates the experimental design. Bar graphs are derived from a representative experiment. The mean track lengths and standard deviation given in parenthesis are derived from n = 3 independent experiments. Statistical significance was determined by a twotailed t-test. At least n = 100 DNA tracks were scored in each condition. Scale bars, 10 µm.
and the ability of Rassf1A genetically null MEFs (Rassf1A −/− ) to form RAD51 filaments on nascent DNA after exposure to HU. In response to either γIR or HU, pS3291-BRCA2 levels decrease but are maintained in the absence of RASSF1A, indicating a greater level of CDK2 activity (Fig. 3c) . Moreover Rassf1A −/− MEFs are unable to form stable Rad51 nucleofilaments in response to HU (Fig. 3b) .
Short HU treatments that do not result in double-strand breaks lead to ATR rather than ATM activation, which then elicits appropriate cellular responses to both protect stalled DNA forks and promote resolution of breaks or lesions 29 . ATM recognition sites have been shown to be frequently targeted by ATR in response to singlestrand breaks or replication stress 42, 43 , prompting us to consider that RASSF1A may be targeted by ATR in response to fork stalling. To this end, U2OS cells were transiently transfected with FLAG-RASSF1A or FLAG-RASSF1A-A133S and exposed to HU in the presence of a specific ATR inhibitor, VE-821. We found that HU treatment elevates phosphorylation of Ser 131 (Fig. 3d, lane 5) ; however, addition of VE-821 inhibits HU-dependent increase in pS131-RASSF1A, indicating that RASSF1A is an ATR target (Fig. 3d, lane 8) . As for ATMmediated targeting, the polymorphic variant did not present any detectable levels of phosphorylation in response to ATR activation (Fig. 3d, lanes 6 and 9) . Taken together, the above data highlight that ATR activates the RASSF1A-LATS1-CDK2 cascade in response to replication stress.
Disruption of the RASSF1A-LATS1 axis leads to genomic instability
Failure to establish RAD51 nucleofilaments on ssDNA during replication stalling leads to MRE11-nuclease-mediated degradation of nascent DNA and subsequent genomic instability [8] [9] [10] [11] . To test whether loss of RASSF1A-LATS1 signalling compromises the stability of nascent DNA at stalled forks we employed DNA fibre analysis to monitor track length of replicated DNA through incorporation of halogenated base analogues that can be detected by immunofluorescence. DNA fibres of Lats1 +/+ , Lats1 −/− and Lats1
−/− cells expressing mycLATS1 did not differ in the length of CldU (nascent DNA; Supplementary Fig. 4a ). However, after 5 h of HU treatment CIdU tracks were shorter in Lats1 −/− MEFs in comparison with Lats1 +/+ MEFs (6.6 ± 0.14 and 10.09 ± 0.2 µm respectively, p = 0.0001) and were restored after re-expression of mycLATS1 (10.3 ± 0.6 µm, p = 0.02; Fig. 4a and Supplementary Fig. 4c ). To establish whether the shorter length of the CIdU tracks in the absence of LATS1 is due to the exposure of the nascent DNA to MRE11 nucleolytic activity, the specific MRE11 inhibitor mirin was used during the HU treatment. Lats1 −/− MEFs that were treated with mirin exhibit CIdU tracks with a similar length to control MEFs (8.9 ± 0.91 and 9.2 ± 0.8 µm respectively; Fig. 4b ). RASSF1A ablation had identical effects on fork integrity (CIdU length in Rassf1A
−/− MEFs of 8.8 ± 0.4 and 5.8 ± 0.3 µm respectively, p = 0.01), which were efficiently rescued by the re-expression of FLAG-RASSF1A (8.08 ± 0.6 µm) but not the polymorphic mutant (5.3 ± 0.1 µm; Fig. 4c and Supplementary Fig. 4b,d ), indicating that ATR phosphorylation of RASSF1A is necessary to protect nascent DNA at stalled forks. Interestingly, both Lats1 −/− and Rassf1A
−/−
MEFs show shorter second-label IdU tracks ( Supplementary Fig. 5a ,b) indicating defective replication restart after the HU removal, which is independent of MRE11 nucleolytic activity (Fig. 4b) . RAD51 has been proposed to facilitate fork regression and formation of a Holliday junction intermediate or 'chickenfoot' , which offers a more favourable substrate for restart 12, 13 and may be regulated by components that protect fork integrity 44 , including RASSF1A and LATS1. To determine whether compromised fork integrity in the absence of the RASSF1A-LATS1 axis leads to genomic instability and properties of defective BRCA2 regulation 2.45 ± 0.4 and Rassf1A +/+ 0.6 ± 0.2 versus Rassf1A −/− 2.45 ± 0.38) indicating that deletion of the RASSF1A-LATS1 axis induces a 'BRCAness' phenotype after exposure to stress (Fig. 5a,b and Supplementary  Fig. 6a) . Similarly, depletion of either LATS1 or RASSF1A from U2OS increased chromosome aberrations (aberrations per metaphase: control 0.5 ± 0.1 versus LATS1 siRNA 1.5 ± 0.21 or RASSF1A siRNA 1.43 ± 0.23, Fig. 5c and Supplementary Fig. 6b ) and the number of micronuclei arising from DNA fragments of broken chromosomes (5.6% in non-targeting (NT) siRNA versus 18.4% in LATS1 siRNA and 18.2% in RASSF1A siRNA respectively, Supplementary Fig. 6d ). Moreover the endemic genomic instability observed in H1299 cells exposed to HU (RASSF1A methylated ) was rescued by re-expression of RASSF1A, but not by the polymorphic variant, explaining the predisposition to tumorigenesis of patients that carry this variant 23 ( Fig. 5d and Supplementary Fig. 6c ). Moreover, depletion of LATS1 with siRNA ablated the RASSF1A-mediated protection of replication stressed H1299 cells, suggesting that RASSF1A contributes to the maintenance of genomic stability through LATS1 ( Fig. 5d and Supplementary Fig. 6c) .
Methylation of RASSF1 is a prognostic factor for poor overall survival in lung cancer and decreased therapeutic efficiency to DNA damaging agents in the clinic 46 . To test our hypothesis that this is due to genomic instability, we used publicly available data from the Cancer Genome Atlas (TCGA) that contains genomic characterization data and sequence analysis of tumour genomes. Using the lung adenocarcinoma cohort, which exhibits frequent hypermethylation of RASSF1, we examined possible correlations between RASSF1A promoter methylation status and copy number variation (CNV) of the genome. In this cohort (TCGA lung adenocarcinoma; April 2014), 188 patients had available data and were separated into two groups based on levels of RASSF1 promoter methylation (low <0.3 and high >0.3) and further divided in 4 subgroups based on the percentage of the genome that was altered (0-0.1%, 0.1-0.2%, 0.2-0.3% and >0.3%). We found an overall correlation between methylation of the RASSF1 promoter and the extent of genomic instability (Fig. 6 ) that is independent of base substitutions ( Supplementary Fig. 7) , indicative of complex rearrangements that occur after collapsed replication forks observed in Fig. 5 . The statistical power is derived from the extremes of the population where relatively stable genomes (<0.1% CNV) have low levels of methylation and unstable genomes (>0.3% CNV) have high methylation of the RASSF1 promoter (p = 0.0054), validating that RASSF1A functions to protect genome integrity (Fig. 6) .
Thus, our data describe how ATR promotes BRCA2-dependent replication fork stability and identify a single nucleotide polymorphism in RASSF1A as an allele exhibiting 'BRCA-ness' . Moreover, epigenetic loss of RASSF1A in sporadic human malignancies similarly deregulates BRCA2 function, providing a link between the poor prognostic value of RASSF1A loss and BRCA-like phenotypes in common cancers.
DISCUSSION
Previous reports highlighted that depletion of LATS1 leads to genomic instability and tumour predisposition 28, 35, 37 . We find that LATS1 safeguards genome stability by ensuring stable RAD51 nucleofilament formation on exposed ssDNA at stalled replication forks (Fig. 7) . This is achieved through activation-induced conformational changes in LATS1 that stimulate interaction with CDKs as originally suggested previously 37 , and similarly is independent of LATS1 kinase activity. Moreover, in line with identification of LATS1 from screens for regulators of DNA damage 28 , the endogenous LATS1-CDK2 interaction occurs in response to replication stress. The core Hippo pathway components, RASSF1A and MST1/2 kinases, are responsible for activation of LATS1 and are inhibited by growth factor receptor signalling, KRAS WT and RAF1 (refs 47-49) . In response to DNA damage, ATM activation results in phosphorylation of RASSF1A on Ser 131, activating MST1/2 and LATS1 kinases leading to YAP-p73 proapoptotic complex formation and inhibition of YAP-TEADmediated malignant transformation 20, 41, 50 . Failure to activate LATS1 in tumours provides support to KRAS MUT -driven oncogenesis through sustained YAP1 transcription 51, 52 . However, inefficient activation of LATS1 is likely to have additional effects than solely regulation of YAP1 (refs 35-37,39) . In this study we show that MST2 activity is also necessary for the establishment of RAD51 foci at stalled forks but YAP1 is dispensable, providing a new insight into how the core Hippo pathway contributes to tumour suppression by maintaining genome integrity.
The authors of refs 8,9 proposed that efficient RAD51 nucleofilament formation on nascent DNA of stalled forks is dependent on RAD51 interaction with the TR2 domain of BRCA2 and cannot be restored by re-expression of classical RAD51-binding Lats1
A R T I C L E S
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Rassf1A -/- BRC repeats alone. We show that ablation of LATS1 leads to increased pS3291-BRCA2 within the TR2 domain, which prevents the formation of RAD51 nucleofilaments during stalling and causes significant shortening in the nascent DNA strands due to MRE11 nucleaolytic activity (Fig. 7) . This is consistent with increased DNA damage; however, the persistent γH2AX foci after treatment with γIR could also indicate defective DNA repair. Although we did not observe defects in homologous recombination, more extensive studies are warranted to determine whether LATS1 plays a role in additional DNA repair pathways. Elevated γH2AX levels may also be attributed to a failure of the fork to restart after resolution of the replication stress. BRCA1/2 and FANCD2 tumour suppressors were originally described as dispensable for restart 8, 9 ; however, fork recovery is also defective in Lats1 −/− and Rassf1A −/− MEFs, which is in line with several studies that indicate a requirement of RAD51 loading for efficient fork restart 12, 13 . Moreover, FANCD2 was recently reported to interact with BLM and facilitate fork recovery after stress 44 . The proposed role for the nascent DNA and fork regression being required for resolution of stalled fork architecture is controversial but would explain the role for RAD51 in restart.
We show that LATS1-CDK2 interaction and establishment of RAD51 nucleofilaments are RASSF1A dependent. RASSF1A is the most common epigenetically inactivated gene in human tumours. An increasing number of studies have shown that RASSF1A methylation positively correlates with therapeutic resistance and poor survival, indicating the potential utility of RASSF1A as a prognostic/diagnostic marker [25] [26] [27] [53] [54] [55] . The RASSF1 c.397G > T single nucleotide polymorphism results in distinct codon usage of alanine instead of serine at position RASSF1A-133. The minor variant has a suboptimal ATM-ATR activation site and has been reported to act as a dominant allele that correlates with worse prognosis and early cancer onset in BRCA1/2-mutation carriers 21, 23, 24 . We demonstrate here that ATR activation is necessary for the triggering of the RASSF1A-LATS1 axis and that RASSF1A-S133 is unable to stimulate the pathway. Moreover, our analysis of lung cancer patients provides a functional insight into how genomic instability and 'BRCA-ness' arises in sporadic tumours and may be identified by RASSF1A methylation in a wide variety of tumour types.
METHODS
Methods and any associated references are available in the online version of the paper. . MEFs were cultured in complete DMEM supplemented with 10% fetal bovine serum in 5% CO 2 and 3% O 2 at 37 • C. U2OS, H1299 and HT1080 cells were purchased from Cancer Research or LGC Promochem (ATCC) and cultured in complete DMEM supplemented with 10% fetal bovine serum in 5% CO 2 and 20% O 2 at 37 • C. To induce replication stress, cells were treated with 2 mM hydroxyurea (Sigma) for the indicated times. All irradiations were carried out using a Gamma Service GSRD1 irradiator containing a Cs137 source. The dose rates of the system, as determined by the supplier, were 1.938 Gy min −1 and 1.233 Gy min −1 depending on the distance from the source. Cancer cells were transfected with plasmid DNA (2.5 µg/10 6 cells) or siRNA (100 nM) using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. MEFs were nucleofected with plasmid DNA or siRNAs using the AMAXA nucleofector (Lonza) according to the manufacturer's instructions. The U2OS DR-GFP stable cell line was produced after transient transfection and puromucin selection (1.5 µg ml −1 ) of the DR-GFP construct (provided by T. Helleday, Karolinska Institute, Sweden). The following siRNA oligonucleotides were used for targeting mouse gene expression: LATS2 GeneSolution siRNA (2801009, Qiagen), mouse MST2 (GeneSolution siRNA (2849859, Qiagen), mouse YAP GeneSolution siRNA (2773920, Qiagen).
myc-LATS1 and myc-LATS1D846A were provided by H. Silljé 57 (Max Planck Institute for Biochemistry, Germany). DR-GFP and I-SceI expression plasmids were provided by T. Helleday. FLAG-RASSF1A and FLAG-RASSF1A-133S were previously described 20, 21 . LATS1 was PCR cloned into the SalI restriction site in the PCMV3b myc-tagged vector. 100LATS1 and 200LATS1 were PCR-cloned into the PCMV3b myc-tagged vector between the ApaI and SalI sites. C-LATS1 (amino acids 1-589) and N-LATS1 (amino acids 589-1130) were PCR-cloned into the PCMV3b myc-tagged vector at the SalI restriction site.
Antibodies.
The following antibodies were used in this study: RAD51 (14B14, GeneTex, GTX702030; 1:500), LATS1 (Bethyl-A300-477; 1:1,000), CDK2 (upstate, 07-631; 1:1,000), CDK1 (Upstate, 06-923; 1:1,000), cyclin A (BF683, Cell Signaling, 4656; 1:1,000), cyclin E (HE12, Cell Signaling, 4129; 1:1,000), cyclin B1 (V152, Cell Signaling, 4135; 1:1,000), Chk1 (G4, Santa Cruz, sc08408), p-Chk1 (Ser 345; Cell Signaling, 2341; 1:300), MST2 (Epitomics, 1943-1; 1:1,000), LATS2 (Novus Biologicals NB200-199; 1:1,000), BRCA2 (2B, Calbiochem, OP95; 1:1,000), BRDU (BU1/75, Oxford Biotechnology, OBT0030G; 1:500), BRDU (B44, Becton Dickinson, 347580; 1:500), GAPDH (Cell Signaling, 2118; 1:10.000), P53BP1 (Novus Biologicals, NB100-304; 1:500), γH2AX (Millipore, 05-636; 1:1,000), myc-Tag (JBW301, Millipore, 05-724; 1:1,000), FLAG-Tag (M2, Sigma, F3165; 1:1,000), pS3291-BRCA2 (provided by F.E.; 1:1,000), pS131-RASSF1A (previously described; 1:1,000; ref.
20).
Immunofluorescence. Cells were grown on coverslips and treated as indicated.
Cells were fixed with 4% paraformaldehyde, permeabilized with 0.3% Triton X-100 and blocked with 2% BSA in 1× PBS. Coverslips were incubated with the indicated antibodies in blocking solution overnight at 4 • C, washed and stained with secondary anti-rabbit and/or anti-mouse IgG conjugated with Alexa-Flour 488 or Alexa-Flour 568 (Molecular Probes) for 1 h at room temperature. Coverslips were washed with PBS+0.1% Tween and DNA was stained with DAPI. Cells were analysed using an LSM780 (Carl Zeiss Microscopy) confocal microscope. For each condition, 200-300 cells were scored.
Immunoprecipitations and western blotting. For LATS1, CDK2 and myc-tagged LATS1 immunoprecipitation, cells were treated as indicated and washed with ice-cold PBS before lysis. Cells were lysed in 0.5% NP-40 lysis buffer (150 mM NaCl, 20 mM HEPES, 0.5 mM EDTA, 1 mM Na 3 VO 4 , complete proteinase inhibitor cocktail (Roche)). Total cell extracts were incubated overnight with 20 µl protein G Dynabeads (Invitrogen) and 2 µg of LATS1, CDK2 or myc-tag antibodies at 4 • C. For FLAG-tag immunoprecipitations RIPA lysis buffer was used (50 mM Tris-HCl, 150 mM NaCl, 2 mM EGTA, 5 mM MgCl 2 , 1% v/v NP40, 1% w/v sodium deoxycholate, 0.1% w/v SDS, 10 mM sodium β-glycerophosphate, 50 mM NaF, 1 mM Na 3 VO 4 , 5 mM sodium pyrophosphate and proteinase inhibitor cocktail EDTA free (Roche)) and total cell extracts were immunoprecipitated with 2 µg FLAG antibody per immunoprecipitation at 4 • C for 3 h. Immunoprecipitates were washed 3 times in lysis buffer. Total cell extracts (corresponding to 10% of the immunoprecipitate) and immunoprecipitates were resolved in 4-12% Bis-Tris Nu-PAGE gels (Invitrogen) and transferred onto PVDF membrane (Millipore) before immunoblotting with the appropriate antibodies overnight at 4 • C. Primary antibody detection was achieved with peroxide-conjugated anti-rabbit or anti-mouse antibodies (Jackson Immunoresearch) and exposure to X-ray film (Kodak). To quantify the bands obtained with western blot analysis, we used ImageJ software (NIH). All bands were normalized against the loading controls. Kinase assay. The CDK2 kinase assay was performed as previously described 16 . Briefly, CDK2 was immunoprecipitated as described above from Lats1 +/+ and Lats1 −/− MEFs. CDK2 immunoprecipitates were incubated with 2 µg of GST-TR2 peptide substrate in kinase buffer (10 mM HEPES-HCl pH 7.6, 50 mM β-glycerophosphate, 50 mM NaCl, 10 mM MgCl 2 , 10 mM MnCl 2 , 5 µM ATP, 1 mM dithiothreitol, 1 µCi [γ-32 P]ATP) for 30 min at 30 • C. After 30 min reactions were stopped by the addition of SDS sample buffer and analysed by SDS-PAGE.
SceI
Metaphase spreads. U2OS and H1299 cells were transfected with the indicated siRNAs or DNA constructs and 48 h post transfection were treated with 2 mM HU for 4 h. After HU removal cells were incubated with 0.1 µg ml −1 colcemid for 4 h. MEFs were treated with 2 mM HU for 4 h and after HU removal with 0.2 µg ml −1 colcemid overnight. Mitotic cells were collected by mitotic shake-off, swollen in hypotonic buffer (10 mM Tris-HCl, pH 7.5, 10 mM NaCl, 5 mM MgCl 2 ) at 37 • C for 5 min and spread onto slides. Chromosomes were stained with DAPI.
Alkaline comet assay. Comet assays were performed as previously described 58 . Cells were trypsinized and embedded in 1% low-melting agarose and lysed in lysis buffer (2.5 M NaCl, 100 mM EDTA, 10 mM Tris base, pH 10.5) for 1 h. Slides were washed, followed by incubation in cold electrophoresis buffer (300 mM NaOH, 1 mM EDTA and 1% dimethylsulphoxide, pH > 13) for 30 min. Electrophoresis was carried out at 25 V, 300 mA for 25 min. Slides were stained with SYBR gold (Invitrogen) after neutralization with 0.5 M Tris-HCl (pH 8.0). Comets were analysed using Komet 5.5 image analysis software (Andor Technology). Fifty cells were counted per slide.
TCGA data analysis. The association of the copy number variation (CNV) frequency and mutation count with the RASSF1 methylation was studied in 554 lung adenocarcinoma patients from the TCGA database for whom complete information on CNV (230), mutation count (231) and RASSF1 methylation (437) was available; 188 cases had both CNV and methylation information; 115 cases had both mutation count and methylation information. The data were downloaded from the cBioPortal for Cancer Genomics 59, 60 In the original version of this Article, the bar chart in Fig. 6 was incorrect; the corrected chart is shown below. This has now been corrected in all online versions of this Article. Statistical significance was determined by a two-tailed t-test. * P< 0.05 (c) Lats1 +/+ , Lats1 -/-and Lats1 -/-cells expressing wt hLATS1 (Lats1 -/-mycLATS1 ) or a hLATS1 kinase dead derivative LATS1-D846A (Lats1 -/-LATS1KD ) were treated with 10 Gy γIR. Total cell extracts were isolated at the indicated time points after irradiation and probed with the indicated antibodies (full panel of antibodies for Fig. 1b) (d,e) U2OS cells were transfected with siRNA against LATS1 or Non Targeting siRNAi (siNT) and exposed to 4 Gy γIR. Cells were either harvested at the indicated time points after irradiation and analysed with Western Blotting for the expression of the indicated antibodies (d) or fixed and processed for immunofluorescence for γH2AX foci formation (e). Bargrahs derived from 15 fields of view from a representative experiment and error bars indicate S.E.M. Statistical significance was determined by a two-tailed t-test, * P< 0.05. (f) Lats1 +/+ , Lats1 -/-, Lats1 -/-mycLATS1 and Lats1 -/-hmycLATS1KD MEFs were treated with 10 Gy γIR and after the indicated time points single-stranded DNA fragments were separated from matured DNA by alkaline single cell electrophoresis. Quantification of the percentage of comet tail DNA after alkaline comet assay for each condition is shown next to representative images. 50 cells were counted per condition in n=3 independent experiments. Error bars derive from n=3 independent experiments and represent standard deviation. Statistical significance was determined by a two-tailed t-test. * P< 0.05. 100 tracks were analysed in each condition in n=3 independent experiments. Statistical significance was determined by a two-tailed t-test. Bar-graphs derived from a representative experiment. 100 tracks were analysed per condition. Mean track lengths and standard deviation given in parenthesis derived from n=3 independent experiments. Statistical significance was determined by a two-tailed t-test. Sketch delineates experimental design. 
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